Cargando…

Evaluation of cystatin C activities against HIV

BACKGROUND & OBJECTIVES: Several host defense proteins known to possess antimicrobial activities are present on mucosal surfaces and are consequently found in body fluids of vertebrates. Naturally occurring protease inhibitors like cystatins, especially cystatin C (cys C), are abundantly present...

Descripción completa

Detalles Bibliográficos
Autores principales: Vernekar, Vandana, Velhal, Shilpa, Bandivdekar, Atmaram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4510722/
https://www.ncbi.nlm.nih.gov/pubmed/26112843
http://dx.doi.org/10.4103/0971-5916.159282
_version_ 1782382225818386432
author Vernekar, Vandana
Velhal, Shilpa
Bandivdekar, Atmaram
author_facet Vernekar, Vandana
Velhal, Shilpa
Bandivdekar, Atmaram
author_sort Vernekar, Vandana
collection PubMed
description BACKGROUND & OBJECTIVES: Several host defense proteins known to possess antimicrobial activities are present on mucosal surfaces and are consequently found in body fluids of vertebrates. Naturally occurring protease inhibitors like cystatins, especially cystatin C (cys C), are abundantly present in human seminal plasma. Although its antiviral activity against herpes simplex virus (HSV) has been demonstrated, the role of this protein against HIV is not well studied. Therefore, the aim of the present study was to evaluate the anti-HIV activities of cys C, which is present innately in the male reproductive tract. METHODS: Protein-protein interaction of cys C with various HIV proteins was studied using a commercially available HIV blot and specific interaction with HIV protease was studied by dot-blot technique using commercially available cys C. To purify biologically active cys C from human seminal plasma to be used for subsequent experiments, gel-permeation chromatography followed by affinity chromatography was used. The HIV infectivity inhibition activity of the purified cystatin C was tested in TZM-bl cells. To study its activity on HIV protease, time-course enzyme kinetics studies were performed using spectrometric assay. RESULTS: Cystatin C reacted with some HIV proteins including HIV protease. Biologically active cys C was purified using gel permeation chromatography followed by affinity chromatography. When tested in TZM-bl cells, purified cystatin C demonstrated HIV-infectivity inhibitory activity (IC(50): 0.28 μM). Enzyme kinetic studies demonstrated that it abrogated the action of HIV protease on its substrate. INTERPRETATION & CONCLUSIONS: The present data demonstrate that cystatin C possesses anti-HIV activities. Molecular models need to be designed with this protein which would assist towards prevention/therapeutics against HIV.
format Online
Article
Text
id pubmed-4510722
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-45107222015-07-30 Evaluation of cystatin C activities against HIV Vernekar, Vandana Velhal, Shilpa Bandivdekar, Atmaram Indian J Med Res Original Article BACKGROUND & OBJECTIVES: Several host defense proteins known to possess antimicrobial activities are present on mucosal surfaces and are consequently found in body fluids of vertebrates. Naturally occurring protease inhibitors like cystatins, especially cystatin C (cys C), are abundantly present in human seminal plasma. Although its antiviral activity against herpes simplex virus (HSV) has been demonstrated, the role of this protein against HIV is not well studied. Therefore, the aim of the present study was to evaluate the anti-HIV activities of cys C, which is present innately in the male reproductive tract. METHODS: Protein-protein interaction of cys C with various HIV proteins was studied using a commercially available HIV blot and specific interaction with HIV protease was studied by dot-blot technique using commercially available cys C. To purify biologically active cys C from human seminal plasma to be used for subsequent experiments, gel-permeation chromatography followed by affinity chromatography was used. The HIV infectivity inhibition activity of the purified cystatin C was tested in TZM-bl cells. To study its activity on HIV protease, time-course enzyme kinetics studies were performed using spectrometric assay. RESULTS: Cystatin C reacted with some HIV proteins including HIV protease. Biologically active cys C was purified using gel permeation chromatography followed by affinity chromatography. When tested in TZM-bl cells, purified cystatin C demonstrated HIV-infectivity inhibitory activity (IC(50): 0.28 μM). Enzyme kinetic studies demonstrated that it abrogated the action of HIV protease on its substrate. INTERPRETATION & CONCLUSIONS: The present data demonstrate that cystatin C possesses anti-HIV activities. Molecular models need to be designed with this protein which would assist towards prevention/therapeutics against HIV. Medknow Publications & Media Pvt Ltd 2015-04 /pmc/articles/PMC4510722/ /pubmed/26112843 http://dx.doi.org/10.4103/0971-5916.159282 Text en Copyright: © Indian Journal of Medical Research http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Vernekar, Vandana
Velhal, Shilpa
Bandivdekar, Atmaram
Evaluation of cystatin C activities against HIV
title Evaluation of cystatin C activities against HIV
title_full Evaluation of cystatin C activities against HIV
title_fullStr Evaluation of cystatin C activities against HIV
title_full_unstemmed Evaluation of cystatin C activities against HIV
title_short Evaluation of cystatin C activities against HIV
title_sort evaluation of cystatin c activities against hiv
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4510722/
https://www.ncbi.nlm.nih.gov/pubmed/26112843
http://dx.doi.org/10.4103/0971-5916.159282
work_keys_str_mv AT vernekarvandana evaluationofcystatincactivitiesagainsthiv
AT velhalshilpa evaluationofcystatincactivitiesagainsthiv
AT bandivdekaratmaram evaluationofcystatincactivitiesagainsthiv